MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 178 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | 0.0% | 0 | -100.0% | 0.00% | – |
Q2 2022 | $15,000 | +15.4% | 482 | 0.0% | 0.00% | – |
Q1 2022 | $13,000 | +30.0% | 482 | 0.0% | 0.00% | – |
Q4 2021 | $10,000 | +11.1% | 482 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -18.2% | 482 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | -15.4% | 482 | 0.0% | 0.00% | – |
Q1 2021 | $13,000 | 0.0% | 482 | -32.1% | 0.00% | – |
Q4 2020 | $13,000 | +8.3% | 710 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -29.4% | 710 | 0.0% | 0.00% | – |
Q2 2020 | $17,000 | -85.7% | 710 | -90.5% | 0.00% | – |
Q2 2018 | $119,000 | – | 7,476 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |